20 / 20 Blog Archive
Apr 12 2021 | Posted In: 20/20 Blog
Palo Alto, CA — The most common strategy for beating the coronavirus is attacking the viral proteins responsible for disease, but the Mahajan Lab and colleagues focused their research on a human protein that interacts with the virus. The Stanford team, working with collaborators at the University...
Apr 5 2021 | Posted In: 20/20 Blog
Palo Alto, CA — Interrupted patient care during the COVID-19 pandemic has been seen across the medical field with dire consequences. In ophthalmology, interrupted care can result in vision loss.
A team of ophthalmologists and clinical research coordinators at Stanford University created a...
Apr 4 2021 | Posted In: 20/20 Blog, Awards
Palo Alto, CA —Young Joo Sun Ph.D., postdoctoral fellow in the Mahajan Lab, received a grant from the Brightfocus Foundation to study a key protein involved in macular degeneration.
Apr 1 2021 | Posted In: 20/20 Blog
Palo Alto, CA —Through funding from The Cancer League, a local cancer charity, Prithvi Mruthyunjaya MD, MHS and Vinit Mahajan MD, PhD, associate professors of ophthalmology at Stanford’s Byers Eye Institute, are the first to identify proteins from inside the eye that predict survival risk in...
Jan 11 2021 | Posted In: 20/20 Blog
Palo Alto, CA — The Mahajan Lab is designing small-molecule injectable drugs for a number of molecular targets they identified using proteomics, the large-scale study of proteins. The ability to surgically inject drugs directly into the eye allows retina surgeons to deliver precise therapies that...
